Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Should you remove your face bandage after 6 hours? new study investigates

NCT ID NCT07441538

Knowledge-focused Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether removing a wound dressing just 6 hours after facial skin surgery is better than keeping it covered for 7 days. 144 adults with benign skin lesions like moles or cysts were randomly assigned to one of the two methods. Researchers checked for swelling, redness, pain, bleeding, and scarring to see which approach leads to better healing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sterile gauze dressing
What this could lead to
If early removal works better, it could simplify wound care after facial surgery and reduce scarring for future patients.
What could go wrong
This is a small, completed study on benign skin lesions only. Results may not apply to other surgeries or people with different skin conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

144 people

The number who actually took part.

Started

Jun 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged between 18 and 60 years * Clinically and postoperatively pathologically diagnosed with a benign facial lesion (e.g., melanocytic nevus, sebaceous cyst, seborrheic keratosis, etc.) and having undergone standard surgical treatment * Voluntarily agree to participate in this study and sign a written informed consent form * Commit to complying with all study procedures and cooperate to complete all follow-up visits and data collection Exclusion Criteria: * Clinically or postoperatively pathologically diagnosed with a malignant facial tumor * Wounds requiring staged excision or planned for secondary intention healing * Surgical site located on or immediately adjacent to a mucosal surface * Known history of allergy to surgical gauze dressings or related materials * Presence of systemic diseases that significantly impair wound healing (e.g., poorly controlled diabetes, immunodeficiency disorders, active infection, etc.) * Concurrent use of medications known to affect wound healing or scar formation (e.g., long-term use of glucocorticoids, immunosuppressants, etc.) * Pregnant or lactating women * Refusal to sign the informed consent form, or are anticipated to have difficulty complying with study follow-up and data collection * Concurrent participation in another interventional clinical trial * Any other factors deemed by the investigator as likely to interfere with the study results or increase the participant's risk

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cyst are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cysts lipoma melanocytic nevus seborrheic keratosis severe cutaneous adverse reaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cyst Lipoma Nevus Scar Seborrheic keratosis (SK)

Contacts and locations

Locations

  • Not Appicable

    Wuhan, Hubei, 430022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.